Novartis Pharmaceutical Administration System, EPO Patent
Summary
The European Patent Office published patent application EP3596635A1, filed by Novartis AG, titled 'System for Administering a Pharmaceutical Product.' The patent covers pharmaceutical administration technology including drug delivery devices and related systems, classified under multiple IPC codes spanning G16H (health informatics), A61M (medical devices), and related categories. The patent is granted with designation across 34 European Patent Convention contracting states.
About this source
GovPing monitors EPO Patent Bulletin - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 45 changes logged to date.
What changed
EPO published patent EP3596635A1 for Novartis AG, covering a system for administering a pharmaceutical product. The invention relates to drug delivery devices and associated health informatics systems as indicated by IPC classifications G16H 20/13, G16H 20/17, G16H 40/63, G16H 40/67, and several A61M medical device classifications.
For pharmaceutical manufacturers, medical device makers, and technology companies developing drug delivery or administration systems, this patent grants Novartis enforceable intellectual property rights across 34 European contracting states. Competitors developing similar pharmaceutical administration technology should review their freedom-to-operate position before commercializing products in these jurisdictions.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEM FOR ADMINISTERING A PHARMACEUTICAL PRODUCT
Publication EP3596635A1 Kind: A1 Apr 15, 2026
Applicants
Novartis AG
Inventors
SCHMIDLIN, Alain, IOBBI, Mario, STUDER, Erich, BRYANT, Andrew
IPC Classifications
G16H 20/13 20180101AFI20260310BHEP G16H 20/17 20180101ALI20260310BHEP G16H 40/63 20180101ALI20260310BHEP G16H 40/67 20180101ALI20260310BHEP A61M 5/20 20060101ALI20260310BHEP A61M 5/24 20060101ALI20260310BHEP A61M 5/142 20060101ALI20260310BHEP A61M 5/14 20060101ALN20260310BHEP G16H 10/65 20180101ALN20260310BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.